Knowledge Center
Patent / Aug 02, 2018
Minocycline base polymorphic forms and its preparation method
Source:
PT 110699 - 20180802
The present invention relates to a minocycline in V cryst. form with a X diffractogram ratio having peaks at 2.9; 5.34; 7.9; 12.94; 15.06; 16.74; 18.22; 19.78; 21.06; 22.26; 23.02; 25.42 ±> 0.2°2θ.Ìý A method preps. the new polymorphic forms IV and V by dissolving and​/or suspending minocycline on the basis of an org. solvent followed by crystn., and their use in pharmaceutical compn.
Ìý
Ìý
Ìý
Also in the Knowledge Center
/ Jan 01, 1973
16.beta.-Methyl-17.alpha.-hydroxypregna-1,4,9(11)-triene-3,20-dione and analogs
Read more
Scientific Article
Scientific Article
/ Jan 01, 1973
21-Sulfuric acid or 21-orthophosphoric acid ester sodium salts of prednisolone or 9.alpha.-fluoro-16.beta.-methylprednisolone
Read more
Scientific Article